[18F]Fluoroazabenzoxazoles as potential amyloid plaque PET tracers: synthesis and in vivo evaluation in rhesus monkey.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Nuclear Medicine and Biology

• Publication date

  2011-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.nucmedbio.2011.04.004PMID 21741254
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nuclear Medicine and Biology

  2012cited by this paper
• PIB binding in aged primate brain: enrichment of high-affinity sites in humans with Alzheimer's disease.

  2011cited by this paper
• The synthesis and preclinical evaluation in rhesus monkey of [18F]MK‐6577 and [11C]CMPyPB glycine transporter 1 positron emission tomography radiotracers

  2011cited by this paper
• Synthesis and Evaluation of 5-Fluoro-2-aryloxazolo[5,4-b]pyridines as β-Amyloid PET Ligands and Identification of MK-3328.

  2011cited by this paper
• In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18)

  2010cited by this paper
• Radiopharmaceuticals for positron emission tomography investigations of Alzheimer’s disease

  2010cited by this paper
• 18F stilbenes and styrylpyridines for PET imaging of A beta plaques in Alzheimer's disease: a miniperspective.

  2010cited by this paper
• Florbetapir (18F-AV-45) PET imaging of {beta}-amyloid plaques is highly correlated with histopathological assays at autopsy

  2010cited by this paper
• Using Cerebral White Matter for Estimation of Nondisplaceable Binding of 5-HT1A Receptors in Temporal Lobe Epilepsy

  2009cited by this paper
• Amyloid Imaging in Alzheimer’s Disease and Other Dementias

  2009cited by this paper
• Preclinical Properties of 18F-AV-45: A PET Agent for Aβ Plaques in the Brain

  2009cited by this paper
• Inverse agonist histamine H3 receptor PET tracers labelled with carbon‐11 or fluorine‐18

  2009cited by this paper
• Evaluation of the novel glycine transporter 1 (GlyT1) tracer [18F]CFpyPB: Dosimetry and brain quantification in human

  2009cited by this paper
• Evaluation of the histamine H3 receptor tracer [11C]MK-8278 in human

  2009cited by this paper
• Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism.

  2008cited by this paper
• Permeability--in vitro assays for assessing drug transporter activity.

  2008cited by this paper
• Recent advances in the development of amyloid imaging agents.

  2007cited by this paper
• [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor

  2007cited by this paper
• PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment

  2007cited by this paper
• Radioligand development for PET imaging of beta-amyloid (Abeta)--current status.

  2007cited by this paper
• Alzheimer disease models and human neuropathology: similarities and differences

  2007cited by this paper
• Forecasting the global burden of Alzheimer's disease

  2007cited by this paper
• Radioligand Development for PET Imaging of β-Amyloid (Aβ)-Current Status

  2007cited by this paper
• Species differences in mGluR5 binding sites in mammalian central nervous system determined using in vitro binding with [18F]F-PEB.

  2007cited by this paper
• 100 Years and Counting: Prospects for Defeating Alzheimer's Disease

  2006cited by this paper
• PET imaging of brain with the β-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer’s disease

  2005cited by this paper
• Binding of the Positron Emission Tomography Tracer Pittsburgh Compound-B Reflects the Amount of Amyloid-β in Alzheimer's Disease Brain But Not in Transgenic Mouse Brain

  2005cited by this paper
• Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis.

  2005cited by this paper
• Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B

  2005cited by this paper
• Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

  2004cited by this paper
• P2-031 Amyloid deposits in transgenic PS1/APP mice do not bind the amyloid pet tracer, PIB, in the same manner as human brain amyloid

  2004cited by this paper
• Improved lesion localization in PET using cluster analysis

  2002cited by this paper
• Alzheimer's disease: genes, proteins, and therapy.

  2001cited by this paper
• In vitro substrate identification studies for p-glycoprotein-mediated transport: species difference and predictability of in vivo results.

  2001influential reference
• A versatile, commercially available automated synthesizer for the development and production of pet radiotracers

  2001cited by this paper
• 2‐[18F]fluoropyridines by no‐carrier‐added nucleophilic aromatic substitution with [18F]FK‐K222—a comparative study

  1999cited by this paper
• Diagnosis of Alzheimer's Disease in a Community Hospital-Based Brain Bank Program

  1997cited by this paper
• Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data

  1996cited by this paper

• Illuminating Tau Aggregates: Multiscale Approaches for Detection, Imaging, and Understanding

  2025cites this paper
• Radiolabeled imaging agents for Alzheimer's disease

  2023cites this paper
• State of the art procedures towards reactive [18F]fluoride in PET tracer synthesis

  2023cites this paper
• Tracer development for PET imaging of proteinopathies.

  2022cites this paper
• Recent Developments in Positron Emission Tomography Tracers for Proteinopathies Imaging in Dementia

  2022cites this paper
• Imaging of Reactive Astrogliosis by Positron Emission Tomography

  2022cites this paper
• Protein and Gene Delivery Systems for Neurodegenerative Disorders: Where Do We Stand Today?

  2022cites this paper
• Positron Emission Tomography in Animal Models of Alzheimer’s Disease Amyloidosis: Translational Implications

  2021cites this paper
• Is Cerebral Amyloid-β Deposition Related to Post-stroke Cognitive Impairment?

  2021cites this paper
• Comprehensive review on design perspective of PET ligands based on β-amyloids, tau and neuroinflammation for diagnostic intervention of Alzheimer’s disease

  2021cites this paper
• PET Radiopharmaceuticals for Alzheimer’s Disease and Parkinson’s Disease Diagnosis, the Current and Future Landscape

  2020cites this paper
• Radiopharmaceutical Sciences

  2020cites this paper
• Small Molecule-Assisted PET: Approaches to Imaging of Conformational Diseases of the Brain

  2017cites this paper
• Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles

  2016cites this paper
• Heterocyclic Scaffolds for the Treatment of Alzheimer's Disease.

  2016cites this paper
• (18)F-Labeling of Arenes and Heteroarenes for Applications in Positron Emission Tomography.

  2016cites this paper
• PET and SPECT Radiotracers for Alzheimer's Disease.

  2015cites this paper
• Pharmacogenomics of Alzheimer's disease: novel therapeutic strategies for drug development.

  2014cites this paper
• Pharmacogenomics in Drug Discovery and Development

  2014cites this paper
• Cognitive Enhancers (Nootropics). Part 1: Drugs interacting with Receptors. Update 2014

  2014cites this paper
• 18F-Labelled Intermediates for Radiosynthesis by Modular Build-Up Reactions: Newer Developments

  2014cites this paper
• Radiolabeled bioactive benzoheterocycles for imaging β-amyloid plaques in Alzheimer's disease.

  2014cites this paper
• Behavioral endophenotypes of drug addiction: Etiological insights from neuroimaging studies.

  2014cites this paper
• Radiotracers Used to Image the Brains of Patients with Alzheimer's Disease

  2014cites this paper
• Automated testsystem of COGNISION headset for cognitive diagnosis.

  2013cites this paper
• Fluorine-18 radiolabeled heterocycles as PET tracers for imaging β-amyloid plaques in Alzheimer's disease.

  2013cites this paper
• 18F labeling of arenes.

  2012cites this paper
• 18F‐Markierung von Arenen

  2012cites this paper
• Synthesis and Evaluation of 5-Fluoro-2-aryloxazolo[5,4-b]pyridines as β-Amyloid PET Ligands and Identification of MK-3328.

  2011cites this paper